Development Partners International (DPI) has invested $190 million in Alameda Healthcare, one of Egypt’s largest private hospital operators, in what is being called the largest private healthcare transaction in the country’s history.
The fresh capital will fuel Alameda’s expansion across Egypt and into the Gulf Cooperation Council (GCC) region, with specific plans for market entries in Saudi Arabia, the UAE, and other GCC countries. Despite the size of the transaction, control of the company remains with Alameda’s Chairman, Fahad Khater. DPI and its partners will take a minority stake, working alongside the existing management team to support growth strategies.
This deal highlights the increasing role of private capital in transforming the healthcare sector, enhancing both the reach and quality of services available in the region.
An integrated healthcare powerhouse
Founded in 1999, Alameda Healthcare has evolved into Egypt’s largest private hospital group, operating more than 1,000 beds across a fully integrated network. It is the only private provider in Egypt with full Joint Commission International (JCI) accreditation across all its hospitals—four of the five JCI-accredited private hospitals in the country fall under the Alameda umbrella.
Alameda’s model spans the full continuum of care, anchored by its Centers of Excellence and focus on specialized, high-acuity treatment. The group’s portfolio includes two flagship tertiary hospitals—As-Salam International and Dar Al Fouad—alongside seven polyclinics, the Elixir Gastro and Liver Care Center, the German Rehabilitation Center, home healthcare provider Tabibi 24/7, and in-house labs, diagnostics, and pharmacies.
Investor perspective: Supporting scalable impact
“This is a milestone transaction for Egypt and for DPI,” said Ziad Abaza, Partner at DPI. “We’re delighted to be supporting Dr. Khater and his mission to deliver world-class healthcare across Egypt and the GCC. We look forward to working closely with Alameda’s leadership to continue expanding our family of hospitals and delivering excellent care to patients.”
DPI is a pan-African private investment firm managing over $3 billion in assets across three funds. Since its inception in 2007, it has focused on high-growth, impact-driven companies across the continent, completing 33 investments and numerous exits. The firm’s healthcare and regional experience are expected to add strategic value to Alameda’s regional ambitions.
“By enhancing Egypt’s position as a destination for medical value travel, we aim to strengthen the country’s role as a regional hub for world-class healthcare services,” Khater. “With DPI’s support, we’re ideally positioned to expand into new markets such as the KSA, UAE, and beyond.”
EFG Hermes acted as sole financial advisor on the transaction. Legal counsel was provided by Addleshaw Goddard LLP (international), ALC Alieldean Weshahi & Partners, and Matouk Bassiouny & Hennawy (local) for Alameda. DPI was represented by White & Case LLP, with additional advisory support from PwC, Debevoise & Plimpton LLP, and Rothschild & Co.
Systemic challenges
While Alameda’s regional expansion reflects growing investor appetite in Egypt’s healthcare sector, the country still grapples with systemic challenges. With only 1.3 hospital beds per 1,000 people, well below international norms, the need for both capacity and innovation remains critical.
Speaking at the U.S.-Egypt Policy Leaders Forum, Deputy Prime Minister and Health Minister Khaled Abdel-Ghaffar emphasized a shift in vision: “We want to move from curing diseases to preventing and predicting them,” he said, highlighting the national genome project and precision medicine as key levers for a future-ready healthcare model.
As Egypt sharpens its focus on preventative care and regional integration, DPI’s landmark investment signals growing confidence in the country’s ability to deliver both medical excellence and sustainable, scalable growth.
